212 related articles for article (PubMed ID: 30518593)
1. Combating escalating harms associated with pharmaceutical opioid use in Australia: the POPPY II study protocol.
Gisev N; Pearson SA; Dobbins T; Currow DC; Blyth F; Larney S; Dunlop A; Mattick RP; Wilson A; Degenhardt L
BMJ Open; 2018 Dec; 8(12):e025840. PubMed ID: 30518593
[TBL] [Abstract][Full Text] [Related]
2. The POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in Australia.
Degenhardt L; Blanch B; Gisev N; Larance B; Pearson S
BMJ Open; 2015 Jan; 5(1):e007030. PubMed ID: 25631315
[TBL] [Abstract][Full Text] [Related]
3. Cohort profile: POPPY II - a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia.
Gisev N; Pearson SA; Dobbins T; Buizen L; Murphy T; Wilson A; Blyth F; Dunlop A; Larney S; Currow DC; Mattick RP; Degenhardt L
BMJ Open; 2023 May; 13(5):e068310. PubMed ID: 37197812
[TBL] [Abstract][Full Text] [Related]
4. Cohort protocol paper: the Pain and Opioids In Treatment (POINT) study.
Campbell G; Mattick R; Bruno R; Larance B; Nielsen S; Cohen M; Lintzeris N; Shand F; Hall WD; Hoban B; Kehler C; Farrell M; Degenhardt L
BMC Pharmacol Toxicol; 2014 Mar; 15():17. PubMed ID: 24646721
[TBL] [Abstract][Full Text] [Related]
5. Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study.
Larney S; Hickman M; Fiellin DA; Dobbins T; Nielsen S; Jones NR; Mattick RP; Ali R; Degenhardt L
BMJ Open; 2018 Aug; 8(8):e025204. PubMed ID: 30082370
[TBL] [Abstract][Full Text] [Related]
6. Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Australia: a protocol for a retrospective observational study.
Nielsen S; Crossin R; Middleton M; Martin C; Wilson J; Lam T; Scott D; Smith K; Lubman D
BMJ Open; 2019 May; 9(5):e029170. PubMed ID: 31138584
[TBL] [Abstract][Full Text] [Related]
7. Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.
Kennedy MC; Crabtree A; Nolan S; Mok WY; Cui Z; Chong M; Slaunwhite A; Ti L
PLoS Med; 2022 Dec; 19(12):e1004123. PubMed ID: 36454732
[TBL] [Abstract][Full Text] [Related]
8. Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids.
Peacock A; Bruno R; Cama E; Kihas I; Larance B; Lintzeris N; Hordern A; White N; Ali R; Degenhardt L
Drug Alcohol Rev; 2015 Nov; 34(6):611-22. PubMed ID: 26084592
[TBL] [Abstract][Full Text] [Related]
9. Risk of adverse events in patients prescribed long-term opioids: A cohort study in the UK Clinical Practice Research Datalink.
Bedson J; Chen Y; Ashworth J; Hayward RA; Dunn KM; Jordan KP
Eur J Pain; 2019 May; 23(5):908-922. PubMed ID: 30620116
[TBL] [Abstract][Full Text] [Related]
10. Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol.
Peacock A; Larance B; Farrell M; Cairns R; Buckley N; Degenhardt L
BMJ Open; 2018 Mar; 8(3):e020006. PubMed ID: 29574444
[TBL] [Abstract][Full Text] [Related]
11. Concurrent prescriptions for opioids and benzodiazepines and risk of opioid overdose: protocol for a retrospective cohort study using linked administrative data.
Liu EY; Tamblyn R; Filion KB; Buckeridge DL
BMJ Open; 2021 Feb; 11(2):e042299. PubMed ID: 33602708
[TBL] [Abstract][Full Text] [Related]
12. Psychosocial safety climate (PSC) and working conditions, predictors of mental health and antidepressant and opioid use in Australia: a study protocol for longitudinal data linkage.
Crispin CN; Afsharian A; Loh MY; Dollard MF; Dormann C; Glozier N; Gill T; Taylor AW
BMJ Open; 2023 Dec; 13(12):e074235. PubMed ID: 38097242
[TBL] [Abstract][Full Text] [Related]
13. Association of Opioids Prescribed to Family Members With Opioid Overdose Among Adolescents and Young Adults.
Nguyen AP; Glanz JM; Narwaney KJ; Binswanger IA
JAMA Netw Open; 2020 Mar; 3(3):e201018. PubMed ID: 32219404
[TBL] [Abstract][Full Text] [Related]
14. Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: A cross-sectional study.
Wei YJ; Chen C; Fillingim R; Schmidt SO; Winterstein AG
PLoS Med; 2019 Nov; 16(11):e1002941. PubMed ID: 31689302
[TBL] [Abstract][Full Text] [Related]
15. Opioid Analgesics in Georgia Medicaid: Trends in Potential Inappropriate Prescribing Practices by Demographic Characteristics, 2009-2014.
Jayawardhana J; Abraham AJ; Perri M
J Manag Care Spec Pharm; 2018 Sep; 24(9):886-894. PubMed ID: 30156455
[TBL] [Abstract][Full Text] [Related]
16. Hospitalisations for non-fatal overdose among people with a history of opioid dependence in New South Wales, Australia, 2001-2018: Findings from the OATS retrospective cohort study.
Jones NR; Hickman M; Larney S; Nielsen S; Ali R; Murphy T; Dobbins T; Fiellin DA; Degenhardt L
Drug Alcohol Depend; 2021 Jan; 218():108354. PubMed ID: 33121866
[TBL] [Abstract][Full Text] [Related]
17. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
18. Australian trends in opioid prescribing for chronic non-cancer pain, 1986-1996.
Bell JR
Med J Aust; 1997 Jul; 167(1):26-9. PubMed ID: 9236756
[TBL] [Abstract][Full Text] [Related]
19. Trends in prior receipt of prescription opioid or adjuvant analgesics among patients with incident opioid use disorder or opioid-related overdose from 2006 to 2016.
Wei YJ; Chen C; Schmidt SO; LoCiganic WH; Winterstein AG
Drug Alcohol Depend; 2019 Nov; 204():107600. PubMed ID: 31586806
[TBL] [Abstract][Full Text] [Related]
20. Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Victoria, Australia from 2013 to 2018.
Nielsen S; Crossin R; Middleton M; Lam T; Wilson J; Scott D; Martin C; Smith K; Lubman D
Addiction; 2020 Jun; 115(6):1075-1087. PubMed ID: 31742765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
